| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Suven Pharmaceuticals Limited (NSE: SUVENPHAR)
SUVENPHAR Technical Analysis
1.5
| As on 19th Apr 2024 SUVENPHAR SHARE Price closed @ 644.55 and we RECOMMEND Buy for LONG-TERM with Stoploss of 582.89 & Sell for SHORT-TERM with Stoploss of 650.25 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SUVENPHARSHARE Price
| Open | 638.85 | Change | Price | % |
| High | 649.90 | 1 Day | -5.85 | -0.90 |
| Low | 632.25 | 1 Week | 18.95 | 3.03 |
| Close | 644.55 | 1 Month | 34.10 | 5.59 |
| Volume | 70598 | 1 Year | 172.50 | 36.54 |
| 52 Week High 621.15 | 52 Week Low 395.05 | ||||
NSE INDIA Most Active Stocks
| IDEA | 12.90 | -2.27% |
| YESBANK | 23.95 | 0.21% |
| GTLINFRA | 1.75 | 0.00% |
| NHPC | 87.15 | -2.63% |
| TATASTEEL | 162.10 | 1.28% |
| SUZLON | 39.35 | -4.37% |
| INDUSTOWER | 351.40 | 2.03% |
| PNB | 128.25 | -1.00% |
| SAIL | 146.05 | 0.86% |
| ZOMATO | 189.20 | 2.16% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
| EXCEL | 0.50 | -9.09% |
| ANMOL | 42.25 | -7.85% |
| SHARDAMOTR | 1504.15 | -5.41% |
| TATACOMM | 1755.20 | -5.33% |
| JUBLPHARMA | 665.00 | -5.09% |
| ARENTERP | 52.10 | -5.01% |
| PVP | 31.30 | -5.01% |
| PVP | 31.30 | -5.01% |
| ARVEE | 237.35 | -5.00% |
| GKWLIMITED | 2531.05 | -5.00% |
| SUVENPHAR Daily Charts |
SUVENPHAR Intraday Charts |
Whats New @ Bazaartrend |
SUVENPHAR Free Analysis |
|
|
SUVENPHAR Important Levels Intraday
| RESISTANCE | 678.56 |
| RESISTANCE | 667.65 |
| RESISTANCE | 660.91 |
| RESISTANCE | 654.17 |
| SUPPORT | 634.93 |
| SUPPORT | 628.19 |
| SUPPORT | 621.45 |
| SUPPORT | 610.54 |
SUVENPHAR Target April 2024
| 4th UP Target | 947.79 |
| 3rd UP Target | 863.86 |
| 2nd UP Target | 811.99 |
| 1st UP Target | 760.11 |
| 1st DOWN Target | 612.09 |
| 2nd DOWN Target | 560.21 |
| 3rd DOWN Target | 508.34 |
| 4th DOWN Target | 424.41 |
SUVENPHAR Weekly Target
| 4th UP Target | 745.46 |
| 3rd UP Target | 707.02 |
| 2nd UP Target | 683.26 |
| 1st UP Target | 659.50 |
| 1st DOWN Target | 591.70 |
| 2nd DOWN Target | 567.94 |
| 3rd DOWN Target | 544.18 |
| 4th DOWN Target | 505.74 |
SUVENPHAR Target2024
| 4th UP Target | 1377.02 |
| 3rd UP Target | 1167.21 |
| 2nd UP Target | 1037.52 |
| 1st UP Target | 907.83 |
| 1st DOWN Target | 537.77 |
| 2nd DOWN Target | 408.08 |
| 3rd DOWN Target | 278.39 |
| 4th DOWN Target | 68.58 |
Suven Pharmaceuticals Limited ( NSE INDIA Symbol : SUVENPHAR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SUVENPHAR Synopsis Technicals View
| 50 Day EMA |
N/A (Short Term) |
N/A | |
| 100 Day EMA | N/A (Mid Term) | N/A | |
| 200 Day EMA | N/A (Long Term) | N/A | |
| MACD (12 26 9) | N/A | N/A | |
| RSI (14) | N/A | N/A | |
| MFI (14) | N/A | N/A | |
| CCI (20) | N/A | N/A | |
| WILLIAM %R (14) | N/A | N/A | |
| ADX (14) | N/A | N/A | |
| PSAR | Stoploss For Long Buy | 336.14 | |
| 10 Day Avg Volume | N/A | ||
SUVENPHAR Other Details
| Segment | EQ | |
| Market Capital | 129853603840.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
SUVENPHAR Address
 |
||
SUVENPHAR Latest News
SUVENPHAR Business Profile
Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is based in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited. Address: # 8-2-334, SDE Serene Chambers, Hyderabad, India, 500034
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service